Atropine Sulfate Injection Shortage: Latest Updates on Availability and Manufacturer Status
The FDA reports a current shortage of Atropine Sulfate Injection due to manufacturing compliance requirements, with varying availability across major suppliers.
What’s in Shortage
Atropine Sulfate Injection (Brand Name: ATROPINE SULFATE) is currently listed in a shortage status by the FDA. This medication is an injection used within the therapeutic categories of Anesthesia, Neurology, and Pediatrics.
Which Manufacturers Are Affected
Several manufacturers are involved in the production of Atropine Sulfate Injection, with varying levels of availability:
-
Accord Healthcare Inc.
- Status: Unavailable
- Details: The 1 mg/1 mL and .4 mg/1 mL presentations have a resupply date of “TBD.” The .05 mg/1 mL and .1 mg/1 mL presentations have been discontinued.
- Contact: 866-941-7875, option 2
-
American Regent, Inc.
- Status: Available
- Details: Both the .4 mg/1 mL and 1 mg/1 mL presentations are currently available.
- Contact: 800-645-1706
-
Fresenius Kabi USA, LLC
- Status: Available
- Details: The .4 mg/1 mL presentation is available. The manufacturer suggests checking wholesalers for current inventory.
- Contact: 888-386-1300
Why There’s a Shortage
According to the FDA, the reason for the current shortage is related to requirements for complying with good manufacturing practices.
What Patients Should Do
Patients who may require this medication for upcoming procedures or neurological care should be aware that while some manufacturers have discontinued certain presentations or are experiencing delays, supply remains available through other sources.
If you have concerns about your treatment, please:
- Consult with your healthcare provider or pharmacist regarding the availability of your medication.
- Contact the manufacturers listed above for specific information regarding their current supply levels.
Disclaimer: Patients should always consult their healthcare provider regarding their medical treatment and any potential concerns about medication availability.
Source
Information provided by the FDA Drug Shortage Database.
- Initial Posting Date: 01/01/2012
- Last Updated: 02/03/2026
Source: FDA Official Notice
Related Articles
Streptozocin (Zanosar) Oncology Medication Facing Ongoing Supply Shortage
FDA · February 11, 2026
Cromolyn Sodium Concentrate (Gastrocrom) Shortage: Current FDA Status and Availability
FDA · February 11, 2026
Quinapril/Hydrochlorothiazide Tablet Shortage: Current FDA Status and Availability Updates
FDA · February 11, 2026